Apotex Launches Pre-Emptive Strike Against Par

Law360, New York (March 15, 2006, 12:00 AM EST) -- A patent squabble has erupted between two generic drug makers, as Apotex Inc. has slapped Par Pharmaceuticals with a lawsuit in hopes of blocking the company from suing it over a generic version of appetite stimulant Megace.

Apotex filed the lawsuit in U.S. District Court for the District of New Jersey last Friday, requesting that the court issue a declaratory judgment regarding four patents held by Par.

The intellectual property covers a generic version of Megace, known as megestrol acetate oral suspension, in addition to the...
To view the full article, register now.